I-124 PET/CT to Predict the Outcome of Blind I-131 Treatment in Patients with Biochemical Recurrence of Differentiated Thyroid Cancer

Autor: Jakob W, Kist, Bart, de Keizer, Manfred, van der Vlies, Adrienne H, Brouwers, Dyde A, Huysmans, Friso M, van der Zant, Rick, Hermsen, Marcel P M, Stokkel, Otto S, Hoekstra, Wouter V, Vogel, Nils R L, Wagenaar

Publikováno v: Journal of Nuclear Medicine, 57(5), 701-707. SOC NUCLEAR MEDICINE INC
Journal of Nuclear Medicine, 57(5), 701-707
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 57(5), 701-7
THYROPET Study Group 2016, ' 124I PET/CT to Predict the Outcome of Blind 131I Treatment in Patients with Biochemical Recurrence of Differentiated Thyroid Cancer : Results of a Multicenter Diagnostic Cohort Study (THYROPET) ', Journal of Nuclear Medicine, vol. 57, no. 5, pp. 701-707 . https://doi.org/10.2967/jnumed.115.168138
Journal of Nuclear Medicine, 57(5), 701-707. Society of Nuclear Medicine Inc.

UNLABELLED: Patients with suspected recurrence from differentiated thyroid carcinoma, based on an increased thyroglobulin (Tg) level and negative neck ultrasound (US), pose a clinical dilemma. Because standard imaging has a low yield identifying pote

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad98e2fcc21ef25b5ac607ca2cbc8459
https://hdl.handle.net/11370/1b623b58-8b72-4b91-aef5-bd4e51934d5e

Influence of Introduction of Positron Emission Tomography on Adherence to Mediastinal Staging Protocols and Performance of Mediastinoscopy

Autor: Frank W.J.M. Smeenk, Michela A. Edelbroek, Martijn Goosens, Sietske A. Smulders, Arent-Jan Michels, Pieter E. Postmus, Astrid B. Donkers-van Rossum, Dyde A. Huysmans, Alette W. Daniëls-Gooszen, Bart A.H.M. van Straten

Publikováno v: Journal of Oncology Practice. 3:242-247

Purpose In this study, we investigated the impact of implementation of [18F] fluorodeoxyglucose positron emission tomography (FDG-PET) in daily practice on adherence to mediastinal staging protocols and performance of mediastinoscopy in non–small-c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc647db2680459666c7e08d4215f9605
https://doi.org/10.1200/jop.0752002

Long-term efficacy of modified-release recombinant human thyrotropin augmented radioiodine therapy for benign multinodular goiter: results from a multicenter, international, randomized, placebo-controlled, dose-selection study

Autor: William Harper, Jean-Louis Wémeau, Hevelyn Noemberg de Souza, Søren Fast, Maria Grazia Castagna, Furio Pacini, Emmanuelle Proust-Lemoine, Irina Rachinsky, Mario Vaisman, Annie Purvis, Laszlo Hegedüs, Christoph Reiners, Rossana Corbo, L Antonangeli, Hans Graf, James Magner, Dyde A. Huysmans, Torquil Watt, Aldo Pinchera, Christopher Marriott, Albert A. Driedger, Angela M. Leung, Peter Grupe, Christian Düren, Lewis E. Braverman

Publikováno v: Fast, S, Hegedus, L, Pacini, F, Pinchera, A, Leung, A M, Vaisman, M, Reiners, C, Wemeau, J-L, Huysmans, D, Harper, W, Rachinsky, I, De Souza, H N, Castagna, M G, Antonangeli, L, Braverman, L E, Corbo, R, Düren, C, Proust-Lemoine, E, Marriott, C, Driedger, A, Grupe, P, Watt, T, Magner, J, Purvis, A & Graf, H 2014, ' Long-term efficacy of modified-release recombinant human thyrotropin augmented radioiodine therapy for benign multinodular goiter : Results from a multicenter, international, randomized, placebo-controlled, dose-selection study ', Thyroid, vol. 24, no. 4, pp. 727-735 . https://doi.org/10.1089/thy.2013.0370

Background: Enhanced reduction of multinodular goiter (MNG) can be achieved by stimulation with recombinant human thyrotropin (rhTSH) before radioiodine ( 131I) therapy. The objective was to compare the long-term efficacy and safety of two low doses

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7313510411f41cb74fc9dabfb64a725
http://hdl.handle.net/11365/973277

Modified-release recombinant human TSH (MRrhTSH) augments the effect of (131)I therapy in benign multinodular goiter: results from a multicenter international, randomized, placebo-controlled study

Autor: Angela M. Leung, M A Edelbroek, Jean-Louis Wémeau, Søren Fast, Torquil Watt, H Noemberg de Souza, Dyde A. Huysmans, L Antonangeli, Chr. Reiners, Rossana Corbo, Furio Pacini, Albert A. Driedger, Mario Vaisman, Peter Grupe, Emmanuelle Proust-Lemoine, L. Hegedüs, C Marriott, James Magner, Irina Rachinsky, Hans Graf, Christian Düren, Mg Castagna, William Harper, Lewis E. Braverman, Aldo Pinchera

Publikováno v: Graf, H, Fast, S, Pacini, F, Pinchera, A, Leung, A, Vaisman, M, Reiners, C, Wemeau, J L, Huysmans, D, Harper, W, Driedger, A, de Souza, H N, Castagna, M G, Antonangeli, L, Braverman, L, Corbo, R, Düren, C, Proust-Lemoine, E, Edelbroek, M A, Marriott, C, Rachinsky, I, Grupe, P, Watt, T, Magner, J & Hegedus, L 2011, ' Modified-Release Recombinant Human TSH (MRrhTSH) Augments the Effect of 131I Therapy in Benign Multinodular Goiter: Results from a Multicenter International, Randomized, Placebo-Controlled Study ', Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 5, pp. 1368-1376 . https://doi.org/10.1210/jc.2010-1193

Background: Recombinant human TSH (rhTSH) can be used to enhance (131)I therapy for shrinkage of multinodular goiter (MG). Objective, Design, and Setting: The objective of the study was to compare the efficacy and safety of 0.01 and 0.03 mg modified-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::551e036733ccb83913a177d71f0fd87c
http://hdl.handle.net/11365/20489

Towards larger volume reduction of nodular goitres by radioiodine therapy: a role for pretreatment with recombinant human thyrotropin?

Autor: Dyde A. Huysmans, Willy-Anne Nieuwlaat, Ad R. M. M. Hermus

Publikováno v: Clinical Endocrinology, 60, 3, pp. 297-9
Clinical Endocrinology, 60, 297-9

Contains fulltext : 59244.pdf (Publisher’s version ) (Open Access)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bea10ba22f02d73448e1b22e99cc7e19
https://pubmed.ncbi.nlm.nih.gov/15008994